Phase 2 Construction of the Company's Brampton
Facility has been Completed
Pure Global Moves Closer to Obtaining Oils
Sales Licensing
Pure Global Launches Expanded Shareholder
Communications Initiative
TORONTO, June 11, 2019 /CNW/ - Pure Global Cannabis Inc.
(TSX.V: PURE; OTC: PRCNF; FRA: 1QS) ("Pure Global" or
"PURE") an integrated, growth-oriented life sciences and
consumer products cannabis company, through its wholly-owned
subsidiary PureSinse Inc. ("PureSinse" or the
"Company"), a Health Canada licensed producer under The
Cannabis Act, is pleased to announce that Phase 2 construction of
the Company's Brampton campus,
housing facilities for vertically farmed cultivation, R&D,
extraction, manufacturing, and distribution, has been completed,
coinciding with a recent on-site inspection for oils sales
licensing by Health Canada.
"We're excited to announce that our manufacturing facility will
soon be operational as we anticipate our first harvest this fall,"
said Pure Global's President & CEO, Malay Panchal. "As Pure
Global moves closer to obtaining our sales license for cannabis
oils, we continue to work to increase brand awareness in the
medical community and increasing direct-to-consumer medical sales.
We're also working closely with cannabis research partners to
collect data in certain key therapeutic areas towards identifying
drug development pathways. We look forward to communicating our
progress and achievements with our stakeholders, and the market as
a whole, in the very near future," added Mr. Panchal.
Phase 2 construction of the Company's Brampton campus is now complete and awaiting
Health Canada approvals. The first phase, completed in 2018,
includes vault storage built to Health Canada Level 9 standards,
extraction, QA and microbiology labs as well as order processing,
packaging, shipping and receiving, security IT and administrative
areas.
The Company plans to begin cultivation and extraction in
mid-summer subject to receiving Health Canada approvals, and
expects its first harvest to be ready for sale in the fall of 2019.
The 18,000 sq. ft. space will act as a hub for vertically farmed
cultivation, R&D, extraction, manufacturing, and distribution.
Phase 2 completion of the main site will also enable PureSinse to
more effectively service patients interested in using extract-based
products. This phase of completion provides an additional six
flowering rooms of about 1,000 sq. ft. each, and includes a tissue
culture lab, processing, drying and mothering rooms, as well as
extraction areas. Coupled with R&D and tissue culture
functions, this site will allow the Company to effectively
cultivate close to three tons annually of cannabis and process
extracts at six tons annual capacity. The third, and final phase,
will expand the facility to 41,000 sq. ft. and include automated
controlled growth cultivation systems that feature the company's
proprietary vertical farming system. Total production capacity is
expected to exceed 20,000 kg/year by the end of
2020. The vertical farming methodology will be validated
on cannabis in phase two for full deployment in Phase 3. Phase 3
will also include a formulations lab, automated packaging, and
scaled manufacturing for cannabidiol ("CBD") health and
beauty and post-derivative products including edibles.
Health Canada recently
completed its on-site inspection for oils sales licensing. As Pure
Global moves closer to obtaining oils sales licensing, it has
expanded production capabilities to include in-house production of
medicated topicals, creams, gels, balms, lotions, tinctures,
sprays, vape pens, oils bottles, and gel capsules. This will boost
the Company's product line capacity to meet the growing demand for
post-derivative cannabis products which would be deployed
throughout the Company's brand ecosystem as edibles and
post-derivative products regulations are expected to come into
being this fall.
Expanded Shareholder Communications Initiative
In support of its shareholder relations initiative, Pure Global
has retained the services of Storyboard Communications Corp.
("Storyboard"), a leading investor relations advisory firm
servicing Canadian small cap companies across the North American
markets.
Storyboard will assist the Company with market intelligence,
investor targeting and events, along with comprehensive creative
and media outreach. Under the terms of the agreement, Pure Global
will pay a monthly retainer of CAD $10,000 for an initial term of 6 months for
ongoing strategic communication and capital markets advisory
services. At the time of entering into this agreement, neither
Storyboard, nor any of its executives have an ownership interest,
directly or indirectly, in Pure Global or its securities, and Pure
Global has not granted Storyboard any right to acquire any such
interests.
The engagement of Storyboard remains subject to the approval of
the TSX Venture Exchange.
About Pure Global Cannabis
Pure Global Cannabis Inc. is an innovation-based cannabis
company led by experienced pharma, biotechnology, horticultural,
and consumer packaged goods (CPG) experts. The company's wholly
owned subsidiary, PureSinse Inc., is a licensed producer under the
Cannabis Act. The company's Brampton campus houses facilities for
vertically farmed cultivation, R&D, extraction, manufacturing,
and distribution. Pure Global will produce branded and
white-labeled cannabis products for the medical, pharmaceutical,
wellness, health & beauty, natural health, food & beverage,
craft, and recreational legal markets with uniquely formulated and
purified concentrates and dried flower. The company is using the
Canadian market as a springboard to develop and manufacture
GMP-compliant premium quality cannabis products for international
sale and distribution with a goal to become one of the most trusted
premium international cannabis brands.
About Storyboard Communications Corp.
Storyboard provides high-quality investor relations and
communications services for small to mid-cap companies in all
sectors, using a unique approach through an innovative methodology.
Storyboard's unique data-driven four-step methodology builds an
in-depth understanding to develop key messaging and optimize
communication strategies.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements,
including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or
the negative or other variations of these words, or similar words
or phrases, have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
and are based on information currently available to management as
at the date hereof.
Forward-looking statements involve significant risk,
uncertainties and assumptions. Many factors could cause actual
results, performance or achievements to differ materially from the
results discussed or implied in the forward-looking statements.
These factors should be considered carefully, and readers should
not place undue reliance on the forward-looking statements.
Although the forward-looking statements contained in this news
release are based upon what management believes to be reasonable
assumptions, Pure Global cannot assure readers that actual results
will be consistent with these forward-looking statements. These
forward-looking statements are made as of the date of this news
release, and Pure Global assumes no obligation to update or revise
them to reflect new events or circumstances, except as required by
law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
To register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter
and Facebook and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.